Persistent DME after anti-VEGF therapy may yield poor long-term vision improvement

BALTIMORE — An increased duration of diabetic macular edema in the first 6 months after treatment with an anti-VEGF agent may be associated with worse long-term vision improvement, according to research presented here.“There’s been a debate for a long time on the correlation between retinal edema and long-term visual acuity,” Scott M. Whitcup, MD, said in an interview with Healio.com/OSN at the Association for Research in Vision and Ophthalmology annual meeting.

Full Story →